Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Medical and surgical robot company in Hong Kong seek $30 million for financing
|Project region||Hong Kong|
|Total value of the target||N/A|
|Expected target net rate of return after deducting all taxes and fees||N/A|
|Validity period of pending order||365|
Senior Associate, International Business Advisory
|Project highlights||R&D medical and surgical company - non-invasive robot system - market scale US $20 billion|
The company is an international medical and surgical R&D robot start-up in Hong Kong, which is led by a strong management team, including 30 year-experienced personnel and other professionals in this field. The market scale of this field is expected to reach US $20 billion and a compound annual growth rate of more than 10% though 2020. Its product has many intellectual property rights, including a magnetic anchor robot system, robot manipulator, etc. The company is now focusing on the development of two revolutionary non-invasive robot systems and seeking $30 million in financing. The first is a disposable soft robot colonoscopy system for colorectal cancer diagnosis which has completed the animal clinical trials and human clinical trials are planned to be conducted in 2020 S2 and are expected to be put into commercial production in 2021. Another is a surgical robot system for colorectal, urological, and gynecological surgery. This robot system is the first in the market to provide forward and reverse surgery, it expands the application field of robot surgery to most abdominal and pelvic surgery processes. The product is now in the preparation stage of clinical trial and is expected to be put into commercial production before 2023.
Enquire for more information about our services, and how we can help solve challenges for your organizationContact Us